Girard Partners’s Magellan Health Services, Inc. MGLN Stock Holding History

Girard Partners’s Portfolio MGLN Stock Details MGLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1	Closed	–	–	898
2018 Q3	$0	Buy	+1	New	+$80	﹤0.01%	973

Other funds holding MGLN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Girard Partners's MGLN Position: Q4 2018 in Review

Girard Partners sold out of Magellan Health Services, Inc. (MGLN) in Q4 2018, closing a stake of 1 share.

Girard Partners first reported a position in MGLN in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 188 funds tracked by Wall St. Rank hold MGLN as of Q4 2018.

Girard Partners reported no remaining Magellan Health Services, Inc. position as of Q4 2018 after selling out during the quarter.
Girard Partners sold 1 Magellan Health Services, Inc. share in Q4 2018.
Girard Partners first reported a position in Magellan Health Services, Inc. in Q3 2018 and held it in 1 quarter.
Girard Partners's Magellan Health Services, Inc. position peaked at $0 in Q3 2018.
188 funds tracked by Wall St. Rank held Magellan Health Services, Inc. as of Q4 2018.

Based on Girard Partners's 13F filing for Q4 2018, filed 11 Feb 2019.